Finally, simvastatin and cetuximab combination therapy in a murine model significantly reduced the proliferation of xenograft Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutated CRC tumors compared to cetuximab alone [211]. This evidence concerns the gene KRAS and colorectal carcinoma.